VEGFR-3 fusion proteins

Research output: PatentScientific

Abstract

The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.
Original languageEnglish
Publication Year9 Sep 2008
Publication statusPublished - 9 Sep 2008
MoE publication typeH1 Granted patent

Cite this

Alitalo, K. K., & Jeltsch, M. M. (2008). VEGFR-3 fusion proteins. (Patent No. US 7,422,741 B2). US Patent and Trademark Office.
Alitalo, Kari Kustaa (Author) ; Jeltsch, Markku Michael (Author). / VEGFR-3 fusion proteins. US Patent and Trademark Office. Patent No.: US 7,422,741 B2. Sep 09, 2008.
@misc{e93676bb1ff34696bf5567c6cf2547d5,
title = "VEGFR-3 fusion proteins",
abstract = "The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.",
author = "Alitalo, {Kari Kustaa} and Jeltsch, {Markku Michael}",
year = "2008",
month = "9",
day = "9",
language = "English",
publisher = "US Patent and Trademark Office",
address = "United States",
type = "Patent",
note = "US 7,422,741 B2",

}

Alitalo, KK & Jeltsch, MM Sep. 09 2008, VEGFR-3 fusion proteins, Patent No. US 7,422,741 B2.

VEGFR-3 fusion proteins. / Alitalo, Kari Kustaa; Jeltsch, Markku Michael.

US Patent and Trademark Office. Patent No.: US 7,422,741 B2. Sep 09, 2008.

Research output: PatentScientific

TY - PAT

T1 - VEGFR-3 fusion proteins

AU - Alitalo, Kari Kustaa

AU - Jeltsch, Markku Michael

PY - 2008/9/9

Y1 - 2008/9/9

N2 - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

AB - The present invention provides materials and methods for antagonizing the function of vascular endothelial growth factor receptors, platelet derived growth factor receptors and other receptors. Soluble binding constructs able to bind vascular endothelial growth factors, platelet derived growth factors, and other ligands are provided.

M3 - Patent

M1 - US 7,422,741 B2

Y2 - 2008/09/09

PB - US Patent and Trademark Office

ER -

Alitalo KK, Jeltsch MM. VEGFR-3 fusion proteins. US 7,422,741 B2. 2008 Sep 9.